In a breast cancer mouse model, delivery of this miRNA mimic led to a reversal of the tumor-suppressive properties of TAMs by acting as a TLR-7 agonist and suppressing IL-10 production, thereby inhibiting tumor growth [101]. The gene discussed is TLR7; the disease is neoplasm.